Graphene and CdS nanocomposite: A facile interface for construction of DNA-based electrochemical biosensor and its application to the determination of Phenformin (cas 114-86-3)
-
Add time:08/26/2019 Source:sciencedirect.com
Graphene/cadmium sulphide (GR-CdS) nanocomposite was synthesized via a low temperature process in aqueous solution. The as-prepared nanocomposite was characterized by scanning electron microscopy, UV–visible spectroscopy, Fourier transform infrared spectroscopy, and X-ray diffraction. The impedance analysis indicated that GR-CdS nanocomposite possessed outstanding electrochemical performance for facile electron transfer. When DNA was immobilized on GR-CdS (DNA/GR-CdS) modified electrode, the electrochemical oxidation of guanine and adenine in DNA residue bases was significantly promoted. Due to the interaction of DNA with phenformin, the voltammetric current of guanine or adenine on the DNA/GR-CdS electrode was decreased when phenformin was present in the electrolytic solution. Under optimized conditions, the signal of guanine on DNA/GR-CdS electrode decreased linearly with increasing the concentration of phenformin in the range of 1.0 × 10−6 mol L−1 to 1.0 × 10−3 mol L−1. The proposed DNA-based electrochemical biosensor was successfully applied to the determination of phenformin in real samples.
We also recommend Trading Suppliers and Manufacturers of Phenformin (cas 114-86-3). Pls Click Website Link as below: cas 114-86-3 suppliers
Prev:Phenformin (cas 114-86-3)-loaded polymeric micelles for targeting both cancer cells and cancer stem cells in vitro and in vivo
Next:Metformin and Phenformin (cas 114-86-3) block the peripheral antinociception induced by diclofenac and indomethacin on the formalin test) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- ArticleLKB1 Inactivation Dictates Therapeutic Response of Non-Small Cell Lung Cancer to the Metabolism Drug Phenformin (cas 114-86-3)08/29/2019
- Molecular and Cellular PharmacologyPhenformin (cas 114-86-3) has a direct inhibitory effect on the ATP-sensitive potassium channel08/28/2019
- Metformin and Phenformin (cas 114-86-3) block the peripheral antinociception induced by diclofenac and indomethacin on the formalin test08/27/2019
- Phenformin (cas 114-86-3)-loaded polymeric micelles for targeting both cancer cells and cancer stem cells in vitro and in vivo08/25/2019
- Original ArticleMelanocytes/MelanomaPhenformin (cas 114-86-3) Inhibits Myeloid-Derived Suppressor Cells and Enhances the Anti-Tumor Activity of PD-1 Blockade in Melanoma08/24/2019
- Original ArticleMelanocytes/MelanomaPhenformin (cas 114-86-3) Enhances the Efficacy of ERK Inhibition in NF1-Mutant Melanoma08/23/2019
- ReportPhenformin (cas 114-86-3), But Not Metformin, Delays Development of T Cell Acute Lymphoblastic Leukemia/Lymphoma via Cell-Autonomous AMPK Activation08/22/2019


